Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
DOI: | 10.1016/S2352-3018(14)00007-1 |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/29598 |
Resumo: | ACTG (AIDS Clinical Trials Group). The IPEC (INI - Fiocruz) site is one of the leading international sites in the ACTG network. |
id |
CRUZ_76cd60366caa62c432a682a79ee8bd08 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/29598 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Gross, RobertZheng, LuLa Rosa, AlbertoSun, XinRosenkranz, Susan L.Cardoso, Sandra WagnerSsali, FrancisCamp, RobGodfrey, CatherineCohn, Susan E.Robbins, Gregory K.Chisada, AnthonyWallis, Carole L.Reynolds, Nancy R.Lu, DarleneSafren, Steven A.Hosey, LaraSevere, PatriceCollier, Ann C.ACTG 5234 team2018-10-17T15:24:34Z2018-10-17T15:24:34Z2015GROSS, Robert. et al. Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial. The Lancet HIV, v. 2, n. 1, p. 12-19, 2015.2405-4704https://www.arca.fiocruz.br/handle/icict/2959810.1016/S2352-3018(14)00007-1ACTG (AIDS Clinical Trials Group). The IPEC (INI - Fiocruz) site is one of the leading international sites in the ACTG network.University of Pennsylvania Perelman School of Medicine, Medicine (Infectious Diseases) and Epidemiology. Philadelphia, PA, USA.Harvard School of Public Health. Biostatistics. Boston, MA, USA.Asociacion Civil IMPACTA Salud y Educacion. Lima, Peru.Harvard School of Public Health. Biostatistics. Boston, MA, USA.Harvard School of Public Health. Biostatistics. Boston, MA, USA.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.Joint Clinical Research Centre. Kampala, Uganda.EUPATI. Barcelona, Spain.National Institute of Allergy and Infectious Diseases. Bethesda, MD, USA.Northwestern University Feinberg School of Medicine. Chicago, IL, USA.Massachusetts General Hospital and Harvard Medical School. Boston, MA, USA.University of Zimbabwe. Harare, Zimbabwe.Lancet Laboratories. Johannesburg, South Africa.Yale University School of Nursing. New Haven, CT USA.Harvard School of Public Health. Biostatistics. Boston, MA, USA.Massachusetts General Hospital and Harvard Medical School. Boston, MA, USA.Social and Scientific Systems. Silver Spring, MD, USA.GHESKIO. Port au Prince, Haiti.University of Washington. Seattle, WA, USA.Adherence is key to the success of antiretroviral therapy. Enhanced partner support might benefit patients with previous treatment failure. We aimed to assess whether an enhanced partner-based support intervention with modified directly observed therapy would improve outcomes with second-line therapy in HIV-infected patients for whom first-line therapy had failed.engPartner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83099https://www.arca.fiocruz.br/bitstream/icict/29598/1/license.txt586c046dcfeef936e32f0323bb9a47c0MD51ORIGINALPartner-based Adherence Intervention for Second-line_Sandra_Cardoso_etal_INI_Lapclin-AIDS_2015.pdfPartner-based Adherence Intervention for Second-line_Sandra_Cardoso_etal_INI_Lapclin-AIDS_2015.pdfapplication/pdf528003https://www.arca.fiocruz.br/bitstream/icict/29598/2/Partner-based%20Adherence%20Intervention%20for%20Second-line_Sandra_Cardoso_etal_INI_Lapclin-AIDS_2015.pdfa3fe5499df665034615b85d576e29bc5MD52TEXTPartner-based Adherence Intervention for Second-line_Sandra_Cardoso_etal_INI_Lapclin-AIDS_2015.pdf.txtPartner-based Adherence Intervention for Second-line_Sandra_Cardoso_etal_INI_Lapclin-AIDS_2015.pdf.txtExtracted texttext/plain43539https://www.arca.fiocruz.br/bitstream/icict/29598/3/Partner-based%20Adherence%20Intervention%20for%20Second-line_Sandra_Cardoso_etal_INI_Lapclin-AIDS_2015.pdf.txtd9bdd6d022e798ff619bf8472a37de71MD53icict/295982019-08-22 08:44:33.491oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352019-08-22T11:44:33Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial |
title |
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial |
spellingShingle |
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial Gross, Robert |
title_short |
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial |
title_full |
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial |
title_fullStr |
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial |
title_full_unstemmed |
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial |
title_sort |
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial |
author |
Gross, Robert |
author_facet |
Gross, Robert Zheng, Lu La Rosa, Alberto Sun, Xin Rosenkranz, Susan L. Cardoso, Sandra Wagner Ssali, Francis Camp, Rob Godfrey, Catherine Cohn, Susan E. Robbins, Gregory K. Chisada, Anthony Wallis, Carole L. Reynolds, Nancy R. Lu, Darlene Safren, Steven A. Hosey, Lara Severe, Patrice Collier, Ann C. ACTG 5234 team |
author_role |
author |
author2 |
Zheng, Lu La Rosa, Alberto Sun, Xin Rosenkranz, Susan L. Cardoso, Sandra Wagner Ssali, Francis Camp, Rob Godfrey, Catherine Cohn, Susan E. Robbins, Gregory K. Chisada, Anthony Wallis, Carole L. Reynolds, Nancy R. Lu, Darlene Safren, Steven A. Hosey, Lara Severe, Patrice Collier, Ann C. ACTG 5234 team |
author2_role |
author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Gross, Robert Zheng, Lu La Rosa, Alberto Sun, Xin Rosenkranz, Susan L. Cardoso, Sandra Wagner Ssali, Francis Camp, Rob Godfrey, Catherine Cohn, Susan E. Robbins, Gregory K. Chisada, Anthony Wallis, Carole L. Reynolds, Nancy R. Lu, Darlene Safren, Steven A. Hosey, Lara Severe, Patrice Collier, Ann C. ACTG 5234 team |
description |
ACTG (AIDS Clinical Trials Group). The IPEC (INI - Fiocruz) site is one of the leading international sites in the ACTG network. |
publishDate |
2015 |
dc.date.issued.fl_str_mv |
2015 |
dc.date.accessioned.fl_str_mv |
2018-10-17T15:24:34Z |
dc.date.available.fl_str_mv |
2018-10-17T15:24:34Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
GROSS, Robert. et al. Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial. The Lancet HIV, v. 2, n. 1, p. 12-19, 2015. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/29598 |
dc.identifier.issn.pt_BR.fl_str_mv |
2405-4704 |
dc.identifier.doi.none.fl_str_mv |
10.1016/S2352-3018(14)00007-1 |
identifier_str_mv |
GROSS, Robert. et al. Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial. The Lancet HIV, v. 2, n. 1, p. 12-19, 2015. 2405-4704 10.1016/S2352-3018(14)00007-1 |
url |
https://www.arca.fiocruz.br/handle/icict/29598 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/29598/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/29598/2/Partner-based%20Adherence%20Intervention%20for%20Second-line_Sandra_Cardoso_etal_INI_Lapclin-AIDS_2015.pdf https://www.arca.fiocruz.br/bitstream/icict/29598/3/Partner-based%20Adherence%20Intervention%20for%20Second-line_Sandra_Cardoso_etal_INI_Lapclin-AIDS_2015.pdf.txt |
bitstream.checksum.fl_str_mv |
586c046dcfeef936e32f0323bb9a47c0 a3fe5499df665034615b85d576e29bc5 d9bdd6d022e798ff619bf8472a37de71 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1822792043351506944 |